{"id":"W2940105550","doi":"10.1016/j.jhepr.2019.02.001","title":"Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Melanoma; Adverse effect; Immune checkpoint; Internal medicine; Immune system; Common Terminology Criteria for Adverse Events; Cancer; Oncology; Immunology; Immunotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805525,0.003290063,0.00254288,0.00485609,0.003488171,0.002662427,0.001931762,0.009866528,0.003496721],"category_scores_gemma":[0.00308116,0.001392538,0.003443621,0.003269029,0.001645159,0.003101116,0.002054439,0.006271545,0.001889995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002659368,"about_ca_system_score_gemma":0.001577876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004792781,"about_ca_topic_score_gemma":0.00640235,"domain_scores_codex":[0.9988191,0.0001538608,0.0001485388,0.0002657235,0.0001957583,0.0004170371],"domain_scores_gemma":[0.9983821,0.0003682229,0.000401914,0.0001266923,0.0001039981,0.0006170011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00001312067,0.00002642296,0.000793124,0.00003556266,0.00001388325,0.997255,0.00007692039,0.00004393987,0.0001604852,0.0001048648,0.0003848542,0.001091808],"study_design_scores_gemma":[0.000009355097,0.00002252729,0.0006510688,0.0000253879,0.00001496354,0.998456,0.00005178681,0.0001307049,0.00008046203,0.00008755695,0.0004627513,0.000007481873],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7625542,0.120282,0.02052944,0.04236823,0.00512117,0.001081647,0.001423917,0.001257328,0.04538204],"genre_scores_gemma":[0.9630631,0.01352973,0.004337836,0.00811691,0.003871329,0.000108305,0.000363172,0.0001180911,0.006491534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009866528,"threshold_uncertainty_score":0.01929516,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01072632906009327,"score_gpt":0.2735513881588859,"score_spread":0.2628250590987927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}